Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pinelopi Manousou

Showing results (1-10 of 86) with videos related to

Pageof 9
Sort By:
Clinical Medicine (London, England)|June 3, 2018
Non-alcoholic fatty liver diseaseJames Maurice, Pinelopi Manousou
The Lancet. Gastroenterology & Hepatology|December 15, 2022
Another arrow in the NASH quiver?Roberta Forlano, Pinelopi Manousou
Clinical Medicine (London, England)|October 6, 2018
ResponseJames B Maurice, Pinelopi Manousou
Journal of Gastrointestinal and Liver Diseases : JGLD|June 27, 2015
Clinical decompensation after achieving SVR with sofosbuvir, daclatasvir and ribavirin in a patient with recurrent HCV post-liver transplantMaria Kalafateli, Geoffrey Dusheiko, Pinelopi Manousou
International Journal of Molecular Sciences|August 12, 2022
Gut Microbiota-A Future Therapeutic Target for People with Non-Alcoholic Fatty Liver Disease: A Systematic ReviewRoberta Forlano, Mathuri Sivakumar, Benjamin H Mullish, et al.
Journal of Hepatology|January 23, 2009
Progression of HCV infection in patients with chronic kidney diseaseEvangelos Cholongitas, Pinelopi Manousou, Dimitrios Samonakis, et al.
Diabetes, Obesity & Metabolism|June 24, 2025
Obesity drives the link between liver fat and depression: Cross-sectional and prospective investigationsQi Feng, Chioma N Izzi-Engbeaya, Pinelopi Manousou, et al.
Cardiovascular Diabetology|January 30, 2026
Measures of comorbid cardiometabolic burden and cardiovascular disease risk in people with MRI-confirmed steatotic liver disease: a prospective cohort studyQi Feng, Pinelopi Manousou, Chioma N Izzi-Engbeaya, et al.
Expert Review of Gastroenterology & Hepatology|February 23, 2019
Non-alcoholic fatty liver disease and cardiovascular risk: an updateBenjamin H Mullish, Roberta Forlano, Pinelopi Manousou, et al.
BMC Gastroenterology|August 1, 2025
Fibrosis status, extrahepatic multimorbidity and all-cause mortality in 53,093 women and 74,377 men with metabolic dysfunction associated steatotic liver disease (MASLD) in UK biobankQi Feng, Chioma N Izzi-Engbeaya, Pinelopi Manousou, et al.
Pageof 9

Showing results (1-10 of 86) with videos related to

Sort By:
Pageof 9
Clinical Medicine (London, England)|June 3, 2018
Non-alcoholic fatty liver diseaseJames Maurice, Pinelopi Manousou
The Lancet. Gastroenterology & Hepatology|December 15, 2022
Another arrow in the NASH quiver?Roberta Forlano, Pinelopi Manousou
Clinical Medicine (London, England)|October 6, 2018
ResponseJames B Maurice, Pinelopi Manousou
Journal of Gastrointestinal and Liver Diseases : JGLD|June 27, 2015
Clinical decompensation after achieving SVR with sofosbuvir, daclatasvir and ribavirin in a patient with recurrent HCV post-liver transplantMaria Kalafateli, Geoffrey Dusheiko, Pinelopi Manousou
International Journal of Molecular Sciences|August 12, 2022
Gut Microbiota-A Future Therapeutic Target for People with Non-Alcoholic Fatty Liver Disease: A Systematic ReviewRoberta Forlano, Mathuri Sivakumar, Benjamin H Mullish, et al.
Journal of Hepatology|January 23, 2009
Progression of HCV infection in patients with chronic kidney diseaseEvangelos Cholongitas, Pinelopi Manousou, Dimitrios Samonakis, et al.
Diabetes, Obesity & Metabolism|June 24, 2025
Obesity drives the link between liver fat and depression: Cross-sectional and prospective investigationsQi Feng, Chioma N Izzi-Engbeaya, Pinelopi Manousou, et al.
Cardiovascular Diabetology|January 30, 2026
Measures of comorbid cardiometabolic burden and cardiovascular disease risk in people with MRI-confirmed steatotic liver disease: a prospective cohort studyQi Feng, Pinelopi Manousou, Chioma N Izzi-Engbeaya, et al.
Expert Review of Gastroenterology & Hepatology|February 23, 2019
Non-alcoholic fatty liver disease and cardiovascular risk: an updateBenjamin H Mullish, Roberta Forlano, Pinelopi Manousou, et al.
BMC Gastroenterology|August 1, 2025
Fibrosis status, extrahepatic multimorbidity and all-cause mortality in 53,093 women and 74,377 men with metabolic dysfunction associated steatotic liver disease (MASLD) in UK biobankQi Feng, Chioma N Izzi-Engbeaya, Pinelopi Manousou, et al.
Pageof 9